Today’s headline is that the Cancer Drugs Fund, which was announced by the Tories in 2010 and ran until 2016, was a ‘huge waste of money’. The Annals of Oncology journal has published a study led by Professor Richard Sullivan of King’s College London, who also described the Fund as a ‘major policy error’.
Defending public services
Battles against privatisation and cuts
After visiting the hospital yesterday to get my oedema looked at, I sat for a while in the small church of St. Bartholomew-the-Less, conveniently located on the way out of the hospital on the way to the bus stop.
Yesterday saw RMT's first ever Disabled Members' Conference, held in London.
Although quite small (9 delegates, plus union officials), the important thing was that it took place at all, especially as rank-and-file members had pushed for its creation against the wishes of the union's national leadership. Now it is established, it will grow from year to year, as the union's other equalities conferences have done.
pic: Committee co-Chairs, Sean McGovern and Janine Booth
We have set up campaign working groups to get more work done on key issues:
This resolution was passed unanimously by RMT Women's Conference 2017.
Janine proposing a motion at RMT Women's Conference calling on the union to reaffirm its commitment to women's right to choose and access abortion, and to mark the 50th anniversary of the Abortion Act by ensuring that there is no return to the days of backstreet abortions. The motion was carried unanimously.
After my breast cancer surgery, the factors which indicate whether I would benefit from chemotherapy were inconclusive. There was one further test available. The Oncotype DX test examines the activity of 21 genes in the tumour tissue of patients with early-stage oestrogen-receptor-positive (ER+) invasive breast cancer and calculates whether chemo will be effective or not.
My score was low (14/100), and so, like many others since this test was developed a few years ago, I do not have to go through the puking, hair-losing agonies of fighting cancer by throwing poisons at it. So far, so good.
So, what’s the catch? My tumour had to be sent to the USA to be tested. This took a few weeks, which delayed the start of my radiotherapy, reducing its effectiveness of in preventing the cancer returning. Radiotherapy is supposed to start within six weeks of surgery; mine started twelve weeks after. Only time will reveal the impact of this delay – but it could mean that my cancer comes back when it would not have done so otherwise.
Each year, there are over 55,000 new diagnoses of breast cancer in the UK, 3,000 new diagnoses of cervical cancer, over 7,000 of ovarian cancer, over 9,000 of uterine cancer, and over 1,000 of vulval cancer. Nearly 12,000 UK women die each year from breast cancer, over 4,000 from ovarian cancer, over 2,000 from uterine cancer, nearly 500 from vulval cancer, and nearly 900 from cervical cancer.
1 in 8 women will develop breast cancer during their lifetime. Think of all the women you know: one in eight of them. Think of all the women in your workplace and in your trade union: one in eight of them.
Research has linked 4-5% of breast cancer cases to shift work, due to circadian (body clock) disruption and exposure to artificial light at night. Studies have shown that breast cancer risk is 21% higher in women who have ever experienced circadian disruption, mainly through night work, compared with those who have not. Exposure to certain substances at work also increases the risk of breast and other women's cancers.